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Abstract
Background: Cure rates for children with cancer in India lag behind that of high-income countries. Various disease,
treatment and socio-economic related factors contribute to this gap including barriers in timely access of
diagnostic and therapeutic care. This study investigated barriers to accessing care from symptom onset to
beginning of treatment, from perspectives of caregivers of children with cancer in India.
Methods: Semi-structured in-depth interviews were conducted with caregivers of children (< 18 years) diagnosed
with cancer in seven tertiary care hospitals across New Delhi and Hyderabad. Purposive sampling to saturation was
used to ensure adequate representation of the child’s gender, age, cancer type, geographical location and
socioeconomic status. Interviews were audio recorded after obtaining informed consent. Thematic content analysis
was conducted and organised using NVivo 11.
Results: Thirty-nine caregivers were interviewed, where three key themes emerged from the narratives: time
intervals to definitive diagnosis and treatment, the importance of social supportive care and the overall
accumulative impacts of the journey. There were two phases encapsulating the experiences of the family: referral
pathways taken to reach the hospital and after reaching the hospital. Most caregivers, especially those from distant
geographical areas had variable and inconsistent referral pathways partly due to poor availability of specialist
doctors and diagnostic facilities outside major cities, influence from family or friends, and long travel times. Upon
reaching the hospital, families mostly from public hospitals faced challenges navigating the hospital facilities,
finding accommodation, and comprehending the diagnosis and treatment pathway. Throughout both phases,
financial constraint was a recurring issue amongst low-income families. The caregiver’s knowledge and awareness
of the disease and health system, religious and social factors were also common barriers.
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Conclusion: This qualitative study highlights and explores some of the barriers to childhood cancer care in India.
Our findings show that referral pathways are intrinsically linked to the treatment experience and there should be
better recognition of the financial and emotional challenges faced by the family that occur prior to definitive
diagnosis and treatment. This information would help inform various stakeholders and contribute to improved
interventions addressing these barriers.
Keywords: Qualitative study, India, Childhood cancer, Accessing care, Referral pathways, Treatment delay, Diagnosis
delay
Background
Access to timely diagnosis and treatment for childhood
cancers in the Indian health care system is often riddled
with multiple barriers [1]. Parents of sick children carry
the burden of caring for the child, themselves and the
rest of the family while trying to unscramble the fastest
and most appropriate pathway to cure. This effort is
often incessant when the disease is serious and requires
long term treatment. Childhood cancer is such an ex-
ample, where the disease nature necessitates timely diag-
nosis and treatment and is the fifth leading cause of
death in India amongst 5–14 year olds [2].
‘Access to health care’ has been defined in various
ways using common theoretical frameworks [3, 4]. Lev-
esque et al. (2013) for example, conceptualised the term
as not only the accessibility of services provided, but the
patient’s ability to seek care, pay for it, reach it and en-
gage with the system [5]. Hence, multiple determinants
influence the journey to appropriate care via the supply-
side of health service provision, organisation and cost of
services, and the demand-side of disease burden, pa-
tient/caregiver knowledge and attitude [5].
One method used to understand and quantify the
challenges to accessing care for childhood cancer is
evaluating the time taken to diagnosis (and occasionally
time to start treatment) from the time of symptom on-
set. These time intervals have mostly been derived using
framework models by Andersen (1995) [6] and Walter
et al. (2012) [7] attributing delays to patient and health
system related factors. Our current understanding about
delays associated with childhood cancer is obtained
mainly from research in high income countries (HICs)
[8–11]. Some Indian studies have quantified the time in-
tervals to diagnosis for various childhood cancers such
as retinoblastoma, leukaemia and meningioma, where in-
tervals ranged from 0.3 to 521 weeks [12–14]. Reasons
for such delays in India included caregiver education
level, geographical distances, job demands of the care-
giver and multiple healthcare referrals, which were
mainly investigated through questionnaires [15, 16].
These provide useful information but lack in-depth ana-
lysis about the interplay of barriers in relation to partici-
pant's feelings, attitudes and behaviours.
Qualitative studies on access to childhood cancer diag-
nosis and treatment are rare in low and middle income
countries (LMICs), where contextual factors such as cul-
tural beliefs in seeking alternate care vs allopathy (appro-
priate care), are likely to be more common to cancer care
pathways than in HICs. Renner and McGill (2016) con-
ducted a study in Ghana using a social constructionist ap-
proach to explore factors influencing parent decision-
making for their child with cancer [17]. Themes emerging
from this study included lack of awareness and knowledge,
seeking traditional medical treatment, need for psycho-
social support and factors related to health financing [17].
A similar study was also conducted by Buckle et al. (2013)
in Uganda and Kenya, to identify health care seeking be-
haviours and factors preventing diagnosis and treatment,
where barriers included financial costs, transportation is-
sues and household responsibilities [18].
Of the few qualitative studies regarding cancer care in
India [19–21], the focus has not been on paediatric oncol-
ogy and the caregiver’s perspective, although the barriers
identified were similar to studies mentioned above. There-
fore, this qualitative study aimed to enrich the existing lit-
erature by interviewing caregivers of children with cancer
and understanding their perspective on barriers to acces-
sing care, which may be at the personal level or health sys-
tem level. It was not designed to evaluate the strengths of
the healthcare system nor the facilitators to accessing care.
Methods
This study was conducted in north (New Delhi) and south
India (Hyderabad) as the lead study investigator (NF) and
interviewers were comfortable with the languages spoken
in these cities (Hindi, Telugu and Urdu). Although both
are large urban metropolitan cities, they are different as
Delhi caters to patients from loco-regional as well as dis-
tant areas and Hyderabad caters mostly to patients from
loco-regional areas. We aimed to recruit hospitals repre-
senting the public sector (n = 3), private sector (n = 3) and
charitable trust sector (n = 1).
Sampling and recruitment
Stratified purposive sampling was conducted across 7
hospitals (4 in Delhi and 3 in Hyderabad). Table 1 shows
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the inclusion and exclusion criteria used. We also aimed
to ensure adequate representation of individuals repre-
senting but not limited to the following categories which
are common in both cities: those with a girl child with
cancer (due to potential of gender bias), families travel-
ling from other states (to ensure family experiences were
not limited to the local cities), those who are below pov-
erty line (BPL) and children with common cancers (e.g.
leukaemia) as well as children with specific tumours
(brain, bone and eye tumours). This purposive sampling
was conducted to ensure barriers identified were not
biased only towards those children and families who
would be the easiest to recruit. At the time of the inter-
view, baseline data were collected for caregivers and
children for age, sex, cancer type, caregiver relationship
and home location. The local principal investigator who
was the lead treating oncologist of each hospital, identi-
fied patients through their patient list and invited care-
givers to participate in the presence of the lead study
investigator. The interviewer and lead study investigator
then privately described the study purpose to caregivers
with the participant information sheet before written in-
formed consent was obtained. It was encouraged that
only primary caregivers directly involved in the day-to-
day care of the child participate. All interviews were
conducted within hospital settings, and depending on
room availability some were conducted privately while
others were conducted in the wards. To avoid discussion
of a sensitive topic around children, arrangements were
always made to leave the child either with another care-
giver or nurse.
Data collection
All interviews were in-depth and semi-structured con-
ducted by an interviewer with tertiary qualifications in
the public health field, who was trained by a local
psychologist (HA) and the lead study investigator. The
interviewer who was fluent in the local language was ac-
companied by the lead study investigator for supervision
and note-taking in each interview. Both researchers en-
sured the topic guide was used throughout the data col-
lection process to avoid any interjection of personal bias.
Questions were designed based on the trajectory of the
journey from symptom onset to diagnosis and treatment.
However, being semi-structured, participants were free
to narrate incidents in no specific chronological order.
Family socioeconomic status (SES) was ascertained
through participant narratives. Participants were asked
to explain their occupation (if none, occupation of the
primary income earner in their household was recorded),
an approximate monthly income for those who wished
to share and those with a BPL card. Based on this infor-
mation, SES was divided into those of BPL, low SES and
those of middle and/or upper SES (white-collar jobs).
Data was collected from various participants until no
new conceptual insights were developed in the iterative
inductive coding stage, and theoretical saturation was
reached.
Data analysis
All participants were de-identified prior to analysis. In-
terviews were transcribed and translated into English
and NVivo 11 software was used to manage and code
the data. For interviews where caregivers wished to be
interviewed in pairs, their responses were analysed to-
gether. Donabedian (1988) and Penchansky’s (1981)
frameworks were initially used to develop a set of broad
deductive codes pertaining to barriers influencing access
to care [3, 4]. NF and JL independently identified com-
mon barriers from literature to further develop a set of
barrier themes (codes), which were then classified into
sub-themes (sub-codes) (Additional file 1: Table S1). NF
and JL compared and discussed the identified sub-codes
to categorize them into a final set of deductive codes re-
lated to individual, health system and disease barriers.
An iterative and inductive approach was then used with
content analysis, where new emerging barriers were also
coded and gradually a “concept driven” perspective [22]
was applied to develop themes. Content analysis was
conducted by one researcher who also collected data
(NF) and triangulated with iterative suggestions and ana-
lytic inputs from a second researcher who was not in-
volved in data collection (SB). In addition, emerging
analysis was also independently discussed with RJ and
AM as part of the analysis process. Given the emotive
nature of the research topic, an important element of
the data collection and analysis was to ensure that po-
tential biases were minimised. This involved firstly sup-
porting the researchers involved through close and
ongoing supervision to manage the emotional intensity
Table 1 Inclusion and exclusion criteria applied to the selection
of participants
Inclusion criteria:
• Children diagnosed with cancers before the age of 18 years
• Diagnosed children who commenced first line treatment (curative
or palliative intent) at the participating treating hospital, no more
than one month prior to date of recruitment
• Children residing in India at the time of onset of symptoms and
have not travelled outside India to seek care
• Children who have a caregiver present at the time of the interview
• Caregivers who can speak the local language or a language known
to the interviewers (Hindi, English, Urdu, Telugu)
Exclusion criteria:
• Non-malignant haematological conditions like thalassemia,
haemophilia
• Those who have presented with relapse during/after treatment
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of the research process. Secondly, we adopted an expli-
citly transparent approach to the analysis and selection
of extracts, where narratives were first discussed
amongst researchers and described in analytical memos
to identify the themes. The researchers then provided
their own interpretation of the narratives as well as
which extracts were most appropriately suited to the
theme. These interpretations were then further discussed
between researchers till a consensus was reached. This
ensured that the patterns of data were appropriately
reflected in the final write-up.
Results
There were two critical phases in the family’s journey from
symptom onset to the start of treatment: referral pathways
taken to get to the treating hospital, and care after reaching
the hospital. Table 2 shows three inter-related themes and
their sub-themes which emerged from the data analysis.
Thirty-nine caregivers were interviewed (15 in Hyderabad
and 19 in New Delhi, with 6 interviews done in pairs) con-
sisting of 17 fathers, 13 mothers, 7 uncles, 1 sister and 1
cousin. Interview duration in Hyderabad generally ranged
from 9 to 20min and 15 to 63min in Delhi. Barriers identi-
fied in both cities did not largely differ and hence results
are presented collectively across participants. Twenty-one
caregivers were of lower SES and BPL and 13 from middle-
upper SES. Patient sample consisted of 16 females and 18
males, aged between 6months to 16 years. They were diag-
nosed with the following cancers: Acute Lymphoblastic
Leukaemia (ALL), Acute Myeloid Leukaemia (AML), Non-
Hodgkin Lymphoma, Brainstem glioma, Medulloblastoma,
Neuroblastoma, Retinoblastoma, Wilms tumour, Rhabdo-
myosarcoma and Primitive Neuroectodermal Tumour
(PNET). Distance to the treating hospital for families resid-
ing outside Delhi or Hyderabad was between 15 km –
1800 km, although total distance travelled could be greater
due to varied referral pathways. More detail of demograph-
ics can be found in Additional file 1: Table S2.
Time: stop, slow down or speed up
The three sub-themes defined in this section were all
crucial components which impacted upon the time
taken to diagnose and treat the child. Sub-theme 1.1 re-
fers to the multiple efforts and avenues undertaken by
caregivers in visiting health care providers in the referral
pathway before reaching the participating treating hos-
pital. These efforts were influenced by determinants
(1.2) such as suggestions by third parties or past experi-
ences within the health system, and paucity of caregiver
and health professional knowledge and awareness of
childhood cancer. Upon reaching the treating hospital,
families then spent time navigating their way through
the hospital (1.3), which was also a contributor to time
taken to receiving definitive diagnosis and care.
Efforts and avenues taken in the referral pathway
Families took multiple efforts and avenues to navigate
the referral pathways. As shown in Fig. 1, those resid-
ing outside Delhi/Hyderabad had more complex path-
ways compared to those living within the city (Fig. 2).
However, a few participants, residing within the city
also experienced more erratic referral pathways con-
sisting of complex visits. The first time interval
occurred during the symptom onset stage. More
prominent symptoms such as nose bleeds or blood in
the urine prompted the family to seek immediate med-
ical care, while some children with symptoms of
fevers, runny nose or cough were treated at home with
general medicines, postponing a visit to the doctor.
Misdiagnoses such as: dengue, jaundice, rheumatoid
arthritis, depression, typhoid, flu, chicken pox, pneu-
monia, diarrhoea and ulcers, also contributed to delay
in reaching the cancer diagnosis. Recurring symptoms
then triggered families to seek care with additional
health care providers, including traditional healers and
rural medical practitioners (RMP).
Even though a few of the regional tertiary hospitals in
north and south India were supposed to be able to treat
Table 2 Themes and sub-themes derived from data analysis
Themes Sub-themes
1. Time
(time interval to diagnosis and treatment)
1.1 Efforts and avenues taken in the referral pathway
1.2 Determinants influencing the referral pathway
1.3 Patient navigation at the treating hospital
2. Importance of social supportive care
(facilitated or depleted support in addition to medical care)
2.1 Religious and cultural beliefs
2.2 Family and social dynamics
2.3 Ability to stay while receiving treatment
2.4 Health care provider-patient support
3. Accumulative impacts of the journey
(overall impacts upon families)
3.1 Financial impacts
3.2 Ongoing emotional and psychological impacts of the pathway
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children with cancer, in reality some basic services re-
quired were unavailable hence families were referred on.
Caregivers often did not question the referrals, however
some participants reported that health care providers
explained the reason as being a lack of essential diagnos-
tic facilities. Sometimes, caregivers themselves sought
other avenues of care due to long admission waiting
times or lack of money. One caregiver (Fig. 1) from the
state of Jharkhand (approx. 1200 km from Delhi) visited
a paediatrician in Patna (state capital of Bihar, approx.
300 km from Jharkhand) three times before being re-
ferred to a tertiary hospital in Kolkata (state of West
Bengal), where he recounts his experience:
The senior doctor said that I cannot treat your child
unless you deposit Rs. 8 lakhs right now. I said ma’am I
cannot deposit so much money now and the NGO said
it would be better if you go to Mumbai. At that time I
started thinking how do I go to Mumbai? (…) So I told
her that ma’am you are sending us away at 5 o’ clock.
You could have told us this same thing the day we came
here so that we could have left immediately. Now at 5 in
the evening where will I go? So I started crying. I said
that how much ever cash I had with me was already
spent. So how will I go? (Father of child with ALL)
Another father also described his confused and ex-
haustive experience of multiple referrals to a paediatri-
cian, orthopaedic surgeon, haematologist and oncologist.
Similarly other caregivers acknowledged the delay in
timely diagnosis:
The thing is that ma’am, we should have gone to the
bigger hospital right at the beginning so that all the
checkup is done. We wasted 3-4 days by going to a
smaller clinic. So maybe if we would have gone to a
bigger hospital then directly it would have been
detected (Mother of child with AML)
Efforts taken to visit multiple doctors were often de-
layed due to geographical issues, especially for those res-
iding far away from diagnostic or treating facilities.
Travelling long distances with a sick child was uncom-
fortable for the family, especially with unreliable public
transport systems. Few families had their own transport,
but difficult terrain often aggravated the situation.
Fig. 1 Typical referral pathway for most families traveling from other cities. This journey is an example of a child diagnosed with ALL in Delhi,
belonging to a village in the state of Jharkhand who then travelled to cities within the states of West Bengal and Bihar before arriving in Delhi.
Note: some of these pathways consisted of repeated visits
Fig. 2 Typical referral pathway for most families residing within the same city as the participating treating centre. This journey is an example of a
child diagnosed with AML in Hyderabad and a child diagnosed with Non-Hodgkin Lymphoma in Delhi. Note: some of these pathways consisted
of repeated visits
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Determinants influencing the referral pathway
Suggestions were offered by relatives, friends or
strangers to seek various medical advice, influencing
caregiver health care-seeking behaviours across all
hospitals. Most families sought allopathy although
few were first influenced to seek treatment through
alternate medicine, or visiting the RMP or traditional
healer:
Yes the local priest in the village. We got the treatment
done through him. Then they had made some
medicines and they also did a plan to exorcise
jaundice (…) Then in the end I spoke to my family
members and showed him to an Ayurvedic doctor in
the area. (Father of child with ALL)
Sometimes the opposite advice fast-tracked the trajectory:
Actually, when we went to Srinagar’s [tertiary
hospital] we met a patient over there. He told me that
if you stay here you will not get cured. Go
straightaway to Delhi as they have so many hospitals
over there. The treatment will be done immediately.
(Uncle of child with ALL)
Mistrust or scepticism of the health system through-
out the referral pathway also contributed to delays.
This was mainly expressed by the male caregivers,
who had a more pivotal role in seeking care. It is
presumed their direct involvement and exposure to
opinions and experiences shaped their pre-conceived
notions of the health system. For example, a few fa-
thers had perceptions of public hospitals being too
overcrowded and involving many processes, while
others ignored advice to conduct tests in a private
hospital.
The issue with government hospitals is that apart from
trouble what else do you get there? They make you run
here and there. (Father of child with Retinoblastoma)
So we had ignored, because basically in India
sometimes private doctors suggest tests for milking
money and all. Everybody knows about it. (Father of
child with ALL)
Poor knowledge of disease and diagnosis/treatment
also acted as a barrier to accessing timely care. Despite
visiting multiple health care providers along the referral
pathway, some caregivers did not recognise the urgency
of the situation to pursue immediate care due to paucity
of knowledge. Some families were unaware of cancer
and those particularly from rural backgrounds or low
SES often questioned the disease aetiology:
I wanted to ask the doctor that since we lie next to
him will we also get the same disease? Because the
mosquitoes which are biting him are biting us as well.
So we should not get the same illness. So this question
was coming up in my mind that how can we prevent
this illness? Can we also get this infection? (Adult
cousin of child with AML)
Many families were unaware of certain tests, radi-
ation or chemotherapy and few thought of research-
ing the disease and procedures while others were
afraid to enquire further. Knowledge impacted care-
giver confidence but also showed their naivety, some
undermining the seriousness of a cancer diagnosis.
Some families were therefore prepared to start treat-
ment immediately but others did not understand the
urgency of timely diagnosis and treatment. For some
caregivers, knowledge increased upon consulting the
treating doctor but was also influenced by other
families:
So only after we came here, we came to know that
this is not a very serious illness. If we are careful
about the food and hygiene then my brother will
become fine again. So that is why I came to
[tertiary hospital] because I had heard that people
do get cured over here and go back. (Adult sister of
child with PNET)
Patient navigation at the treating hospital
Many families experienced problems in navigating the
treating hospital across both cities, especially those
who were uneducated. This problem was more preva-
lent in public hospitals as compared to private hospi-
tals. Time intensive bureaucratic tasks were stressful
and discouraging for caregivers rushing to commence
treatment. Time was wasted in locating rooms, long
queues, completing administrative procedures such as
filling forms, applying for reimbursements and regis-
tering for diagnostic tests. One teenage boy suffering
from PNET took on the labourious administrative
tasks himself, including waiting in long queues as de-
scribed by his mother:
We have to wait for 4 to 5 hours at times. My son
wakes up at 3am and gets the [registration] number.
Then he tells me that mother you eat and come, I will
go ahead. (Mother of child with PNET)
Another mother described her experience in a public
hospital before getting her daughter’s bone marrow bi-
opsy done in a private hospital:
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Ma’am if we would take our child over there again,
then they would have killed her. Because they give
such dates that the person will die before that.
(Mother of child with ALL)
From the narratives, time estimation between symp-
tom onset and starting the treatment ranged from three
weeks to a year, with most families reporting a duration
of more than 6months. Few families had limited visits
and were diagnosed at tertiary hospitals near their native
home place. Some families from middle-upper SES had
more connections with specialists and better knowledge of
the referral pathways and treating hospitals than lower
SES families, and this advanced their progression toward
diagnosis and treatment. Referral pathways for children
being treated in Delhi hospitals were more diverse than
those treated in Hyderabad. Most families from districts
in and around Andhra Pradesh and Telangana had Hy-
derabad tertiary hospitals as the second or third visit,
where they often got a definitive diagnosis and treatment.
Families from north Indian states however, had more ter-
tiary hospitals to choose from, either in a neighbouring
state or close metropolitan city making their journey lon-
ger, although most did not have appropriate diagnosis and
treating facilities for children with cancer.
Importance of social supportive care
Although medical care was received intermittently
throughout the referral pathway and mainly upon reach-
ing the participating treating hospital, families across
both cities often spoke about the need for social support
while accessing medical care. Families relied on religious
and cultural beliefs (2.1) and it was important to under-
stand the family and social dynamics (2.2) in supporting
the primary caregiver financially, emotionally and its
subsequent effect on the child. Secondly, upon starting
treatment, the ability to stay while receiving treatment
(2.3) and health care provider-patient support (2.4) also
affected access to medical care.
Religious and cultural beliefs
Religious and sociocultural beliefs influenced the type of
support families sought throughout the journey. Alter-
nate treatment was sometimes sought upon symptom
onset, and re-visited in conjunction to allopathic care.
Although this was more prevalent amongst families from
rural or low SES, middle-upper class families also sought
alternative care such as one businessman who was treat-
ing his son in a private hospital:
We took him to Haridwar to a Vaid1 and his
medicines are being given to him. Then we are also
giving him the paneer2 made from the milk of the best
cow called Gir Gai. And we are also feeding him the
pure urine of that cow’s calf as well. (Father of child
with Medulloblastoma)
All families expressed a degree of relief using reli-
gious means and attributed cause of disease to either
an ‘evil eye’, fate or God. Religious influence was also
predominant in affecting financial support, showing
the extent to which religion played a big role in
accessing care:
Among Muslims we don’t even believe in getting
insurance done. It is supposed to be illegal. All of that
is unnecessary. (Father of child with ALL)
Family and social dynamics
The impact of social and relational roles was evident in
the type of support received throughout the journey in
both cities. Parents often had to manage other responsibil-
ities apart from taking time out to care for the sick child.
Firstly, the opinions of male caregivers regarding the
health system (section 1.2) demonstrated that husbands
were usually the ones to take the child for health care
visits, make decisions and navigate the health system while
the female caregivers engaged more in domestic house
work. While the shared responsibility might have acceler-
ated the journey, the process was still hindered over time
with increasing duties and concerns over the treatment.
Secondly, some caregivers were unable to pursue care
due to resource constraints, which were often deliber-
ately withheld by relatives due to domestic conflicts and
different set of ideologies. Due to lack of money, one
caregiver along with her husband felt it was easier to let
her child die naturally believing they could produce
more children later who would be healthy:
They thought of not getting the treatment done since it
was their first child. They thought of ignoring it is
what I felt. They would have ignored and taken her
back and left her to her fate. (Uncle of child with
Wilms tumour)
Upon reaching the treating hospital, caregivers
expressed momentary relief regarding the diagnosis and
starting treatment and their confidence grew upon see-
ing other children also receiving similar treatment.
However, some were also apprehensive about the hos-
pital environment. With little to no social support,
caregivers from other cities expressed confusion, worry
and felt uneasy staying in a new city with unknown
1practitioner of Ayurvedic medicine 2cottage cheese
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people, especially those who were uneducated and
from rural backgrounds. Some caregivers spoke of
situations of receiving no social support from rela-
tives or friends and leaving behind dependent family
members:
The biggest problem is that I have two children whom
I have left and come here. My brother is no more. She
is my brother’s daughter. I have left everyone and
come here since 15 days now. (Uncle of child with
Retinoblastoma)
Others expressed gratitude and the significance of a
helping family member or non-medical staff of the
hospital.
Ability to stay while receiving treatment
A crucial barrier to being able to stay for diagnosis
and treatment upon reaching the cancer hospital is
finding accommodation. Some caregivers from other
cities, particularly those caregivers from a lower SES,
were forced to sleep on footpaths, next to metro sta-
tions or in government run homeless shelters. This
was similar across both cities. The ongoing tests and
appointments meant they had to find accommodation
close by, and often the child’s health would deterior-
ate to the point of requiring emergency care. Due to
this, even though some families were offered accom-
modation on the outskirts of the city, they refused it.
I spend the day here and I stay on the road at
night (…) I am lying here till evening and I don’t
even get food to eat. I don’t get a chance to bathe
for 2-3 days at a stretch. (Father of child with
Rhabdomyosarcoma)
Once treatment began, caregivers are recommended
to provide home cooked food to the patient, which
proved challenging for those without appropriate ac-
commodation or facilities. Families including the sick
child then resort to eating local unhygienic street
food, worsening the condition:
We couldn’t even change our clothes here properly.
We would wear the same two sets of clothes
regularly for 5 days (…) Today in the morning we
had rice and the rice was such that when we
made balls out of it and threw it then it started
bouncing like plastic. So I don’t know if the rice
was made of plastic or not. So that is why we are
managing with whatever we are getting. We had
thought that if we get a place to stay then we
[could store] flour and water and everything.
(Adult cousin of child with AML)
Health care provider-patient support
Some caregivers recounted negative experiences from
certain health care providers during the referral pathway,
where the doctor’s dismissive attitude and inconsistent
referrals made them feel insignificant and helpless to
progress through the journey:
They gave us too much trouble. She was in a lot of
pain. When I would take her to emergency they would
say why have you got her here. Take her there! (…)
They said they cannot do anything more for her so
take her away. (…) [Then] we showed in [out-patient
department] but they said go back and show her in
emergency. This is how they behaved with us. (Mother
of child with ALL)
Upon reaching the treating hospital, the doctor-caregiver
relationship was again a recurring matter, where some care-
givers expressed confusion, lack of trust and disappoint-
ment in health care providers in selected hospitals, while
others were satisfied. Upon paying for treatment, a few
caregivers appreciated the government or private health
insurance schemes available to them, while others were
dissatisfied with the application process or financial cover-
age received. Non-governmental organisations (NGOs) and
social worker teams in all hospitals played an important
role in supporting those families who were aware of these
services. However, unfortunately not all caregivers were
aware of the existence of these NGOs.
Accumulative impacts of the journey
There was a clear connection between pathways taken
and its accumulated impacts upon families in both
cities. Financial impact (3.1) was a common problem
for all families which affected the time taken, social
relations and quality of care. Ongoing emotional and
psychological impacts of the pathway (3.2) refers to
the experiences of the caregiver and child resulting in
a variety of emotions which facilitated or depleted the
will to persevere.
Financial impacts
Financial problems were common for families across
both cities. Few families from a middle-upper SES
had full or part insurance for their child. Most fam-
ilies who live below the poverty line obtained free or
subsidized treatment from state or national govern-
ment schemes, however some families first had to
pay upfront. To pay all expenses most caregivers re-
ported selling off livestock or personal properties
and borrowing money or taking a loan. In addition,
all caregivers who were the primary breadwinners of
the family, had to take leave from work resulting in
a loss of income:
Faruqui et al. BMC Public Health         (2019) 19:1613 Page 8 of 12
He sells vegetables on the cart. The work mainly
happens in the evening and the radiation also takes
place mainly in the evening. So that becomes a
problem because we have to leave the work and come
here (Adult cousin of child with Brainstem Glioma)
Caregivers who were dependent on their spouse’s in-
come faced an additional challenge of leaving behind
other children to bring the sick child for treatment. Fi-
nancial impacts were also felt due to external influences,
such as the Indian government’s 2017 demonetization
policy, where certain Rupee notes became invalid to use,
resulting in families unable to spend money to access
care. Many caregivers from middle-upper SES acknowl-
edged and empathised with families of lower SES who
had financial problems.
Ongoing emotional and psychological impacts of the
pathway
Some families recalled sensitive incidents during the re-
ferral pathway that burdened them psychologically, espe-
cially due to the relationship dynamics between health
care providers and families. One father described the
situation of being referred back and forth between two
hospitals with his daughter who was suffering from ex-
treme body pain:
After going there I felt my condition was like a dog.
The child was in so much difficulty and was just
wrapped in a towel the entire night crying. (Father of
child with ALL)
Impacts were also felt beyond the patient’s family,
where additional support was sometimes offered from
the community. However, negative psychological and
emotional impacts were common across all caregivers
interviewed in both cities. Worry, especially over the dis-
ease diagnosis, was expressed by all caregivers who
understood the diagnosis of cancer:
So I showed the doctor the report and they told me
this was the case. I got really scared and started
feeling dizzy and I fell. (Mother of child with Non-
Hodgkin Lymphoma)
In addition, negative influences from either family or
community also placed an added burden upon
caregivers:
Others say that this cannot be cured. Why do they say
so? They should give the confidence that it can be
cured. What has the child done? It’s not fair for such
small innocent children to bear this pain. Sometimes I
feel instead of seeing this, the child should not have
arrived into the world. (Mother of child with Ewing’s
Sarcoma)
Caregivers also expressed concern for their own health
in many interviews as well as the emotional and psycho-
logical impacts upon the child, where older patients who
could comprehend the situation expressed their anguish
more apparently:
I said Sir please check her (…) I am not lying. She is in
a lot of pain. So he said that I cannot admit her and
just referred her to a neurologist saying that the child
has some problem with her brain (…) The child
started crying, she started saying that mother even
though I am not crazy they will definitely make me
mad now. So I said forget it child, don’t worry. We will
consult someone else. (Mother of child with ALL)
Discussion
The journey to accessing appropriate health care for chil-
dren with cancer in India is multifaceted and there is a
labyrinth of pathways. Reflecting the realities of partici-
pants’ lives, the themes delineated within the data are inter-
connected even though each experience was unique.
Families in north India travelled greater distances to Delhi
than those traveling to Hyderabad. The duration of inter-
views was also longer for participants in Delhi. These par-
ticipants narrated more experiences coming to Delhi which
consisted of more complex pathways and health care pro-
vider visits compared to participants in south India. Cul-
tural diversity of expression between north and south
Indians may also be a contributor to varied narratives. Fam-
ilies in public hospitals were mostly from a lower SES and
experienced more barriers compared to families receiving
care in private hospitals or of higher SES. Although we did
not seek to capture SES data using any standardised instru-
ments, the caregiver occupation, narratives of situations
where families had literacy difficulty and financial barriers
were evidence enough for distinguishing families from
lower and middle/upper socioeconomic backgrounds.
Time intervals along the path to appropriate care were
influenced by the number of visits to various health care
providers, the type of services available and the quality of
social support offered, which in turn was influenced by the
cumulative financial and emotional impacts. The occur-
rence of misdiagnoses during the symptom onset stage may
be reflective of poor awareness and sensitization of child-
hood cancers by general practitioners leading to a delay in
diagnosis [16]. The lack of essential diagnostic facilities at
certain provider visits contributed to erratic referral path-
ways, highlighting the weak health system structure in re-
gional areas, forcing families to seek care further away from
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home. This inadequacy in service availability coupled with
a mistrust in the health system, contributed to greater de-
lays. Perceptions that some hospitals fare better than others,
or that hospitals would have fastened the diagnostic pace
compared to smaller private clinics, were examples of mis-
trust and scepticism of the system which could have also
potentially hindered the decision making process of care-
seeking. In addition, even upon reaching the treatment
centre, patient navigation issues within the hospital due to
administrative and bureaucractic tasks or long waiting
times, showed that health system barriers continued to im-
pede the journey to timely care.
The complexity of the system and emotional burden
of the process means that pursuing care pathways re-
quired considerable resilience, clarity of thought,
patience and motivation by caregivers. Hence, an im-
portant part of strengthening the health system for
childhood cancer care (and a pivotal theme in our find-
ings) is the need for psychosocial and supportive care in
reducing the undesirable effects of delay and the nega-
tive impacts of the diagnosis on emotions and resources.
This has also been reflected in other settings highlight-
ing the need to reduce a universally distressing and po-
tentially traumatic experience for all families [23–26].
The demands of the referral pathway depleted care-
giver capacity to engage positively, impacting on early
commitment to treatment success and impeding their
overall access to appropriate care. The amount of emo-
tional, social, financial and informational support re-
quired was correlated with time taken to reach definitive
diagnosis and care. A systematic review by Brocken et al.
(2012) revealed that rapid diagnostic pathways reduced
the period of diagnosis-related distress and showed an
“absence of a detrimental effect on anxiety” [27]. Al-
though the study focused on adult patients, it showed
reduced period of uncertainty and better patient satisfac-
tion through “one or two-stop diagnostic services” [27].
Such interventions can be equally useful for diagnosed
children, positively impacting time taken.
Apart from suggestions provided by friends or rela-
tives to quicken the journey, caregivers did not men-
tion any additional information of benefit provided by
health care providers during the referral pathway.
Moreover, referrals were sometimes done in a manner
which was dismissive or obscure, leading to pre-
conceived notions of the health system (as mentioned
above) and caregiver demotivation. Blazin et al. (2018)
reported that effective communication skills by health
care providers fostered comfort and better coping
mechanisms for families throughout the journey [28].
Mack et al. (2007) also reinforced that even if health
outcomes were poor, parents in the US experienced
hope when prognostic information was appropriately
communicated [29]. A positive experience with health
professional attitudes prior to treatment was largely
not the case in our results and this varied upon treat-
ment experience between public and private hospitals.
However, apart from behavioural interactions, family
dynamics in the Indian culture may also lead to im-
proper patient-provider relations. An example is the
phenomenon of ‘collusion’, where upon one caregiver’s
request, health care providers may withhold diagnosis
information to other caregivers involved, leading to
varied patient-provider experiences [30].
Understanding the context of the caregiver’s social
and relational circumstances during the journey was
critical. A general common barrier amongst care-
givers was the poor knowledge and awareness of the
disease and treatment, reflecting the need for educa-
tion efforts and community sensitisation towards
childhood cancers. However, if caregivers understood
the seriousness of the diagnosis earlier on and had
the resources, it is likely that social/relational re-
sponsibilities would still impede caregiver ability to
singularly focus on the medical journey. It was also
important to note that men mostly navigated the
health system to seek care, while women were cul-
turally expected to raise the children and stay at
home attending to the child and domestic tasks.
While this was not the case for all families, the cul-
tural predisposition highlighted a deficit on success-
ful care-seeking pathways.
Many families expressed momentary relief of obtain-
ing a final diagnosis and commencing treatment upon
reaching the treating hospital, receiving help from
NGOs and social workers and upon seeing other fam-
ilies facing the same battle. This was reflective of the
exhaustion and fear experienced during the referral
pathway and an indicator of the solitary nature of this
journey. Others expressed frustration which reflected
the cumulative effects experienced, especially when
recalling sensitive incidents during the referral path-
way, influencing their engagement during the treat-
ment phase. During interviews, many caregivers cried
while recalling what had occurred yet feeling inclined
to focus on the present needs given the timing of the
interview. This illustrated the emotional intensity in
shaping present experiences. It again draws the dire
need of enhancing quality of care through compas-
sionate social workers, doctors and NGOs. These
small acts of compassion were indeed recognised in
a few caregiver narratives and must not be underesti-
mated for improving ongoing engagement in care.
Referral pathways are intrinsically linked to the
treatment experience and is also important in address-
ing abandonment of care which is relatively common
in LMICs [31]. When the topic of access to care is ex-
amined, it is often examined with referrals prior to
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diagnosis and treatment as separate. Psychosocial
supportive care deficits are often unseen or viewed
separately to the treatment experience but are an im-
portant part of the entire care continuum. While re-
ferral pathways cannot be improved by specialist
cancer treatment hospitals alone, there can be greater
recognition of the family’s emotional and resource de-
pletion that occurred along the journey to diagnosis,
which may positively affect the way health services
are provided and received upon treatment commence-
ment. It is worth pointing out that this study was de-
signed to focus on barriers to accessing care. We
believe that despite these barriers, there are strengths
in the system as well. This is because the system con-
tinues to assist and manage a large number of pa-
tients in many centres, with minimal cost to patients
due to government support.
Conclusion
This qualitative study provides an in-depth under-
standing and evidence to further explain the problem
identified through quantitative research on time inter-
vals for childhood cancer treatment in India. It high-
lights the impacts of the referral pathways upon the
patient’s and family’s treatment experience. Limita-
tions of this study were that we sought to understand
experiences from symptom onset up to the initial
stage of treatment and were unable to capture the ex-
periences of families undergoing treatment throughout
the cancer journey. Future research could expand to
follow families into their treatment. In addition, it is
also important to recruit and study experiences of
those children and families who never reached the
treatment centre. However, we believe that most of
the barriers identified in this study would also apply
to those patients who never started treatment. We ac-
knowledge that despite our best efforts to ensure par-
ticipant confidence in narrating stories within the
hospital premises, there is a possibility with such
studies that respondents may not share all the infor-
mation or may modify it. It is therefore imperative
that studies ensure fidelity of the research by invest-
ing time in the participant information process to
gain participant confidence before letting them nar-
rate the experiences. The need for support was not
only evident through narratives, but also through
caregivers who expressed gratitude post interviews for
giving them an opportunity to narrate their experi-
ences. This study highlights the need for hospital
based counselling services for families. While collect-
ive support can either enable or disable a referral
pathway, improving access for childhood cancers
should be defined as both timely and less traumatic.
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